Findings published in Science Immunology resolve how human LAG-3 binds to its main ligand providing a better foundation for ...

Clinical-stage company Immutep (ASX:IMM) has announced new findings published in Science Immunology that resolve how human ...

A study published in Nature Communications examined the use of calcium carbonate nanoparticles (CNPs) to improve the ...

MDX-2001 (Modex Therapeutics Inc.) was engineered as a potentially first-in-class tetraspecific lymphocyte activator and survival enhancement receptor (LASER) recognizing CD3 and CD28 on human T cells ...

Gradual lymphocyte activation with IL-12 partial agonist STK-026 maintains anti-tumor efficacy but escapes acute NK-mediated cytokine release and toxicities associated with WT IL-12 Session Name ...